Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis

被引：53
|
作者：
Markowitz, Martin [1 ]
Grossman, Howard [2 ]
Anderson, Peter L. [3 ]
Grant, Robert [4 ]
Gandhi, Monica [4 ]
Horng, Howard [4 ]
Mohri, Hiroshi [1 ]
机构：
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA
[2] Cleveland Clin Florida, Weston, FL 33331 USA
[3] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
[4] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2017年 / 76卷 / 04期
关键词：
ANTIRETROVIRAL THERAPY; TRANSMISSION; RISK; MEN;
D O I：
10.1097/QAI.0000000000001534
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E104 / E106
页数：3
相关论文
共 50 条
  • [1] Multidrug-Resistant HIV-1 Infection despite Preexposure Prophylaxis
    Knox, David C.
    Anderson, Peter L.
    Harrigan, P. Richard
    Tan, Darrell H. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (05): : 501 - 502
  • [2] Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis
    Colby, Donn J.
    Kroon, Eugene
    Sacdalan, Carlo
    Gandhi, Monica
    Grant, Robert M.
    Phanuphak, Praphan
    Ananworanich, Jintanat
    Robb, Merlin L.
    Phanuphak, Nittaya
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (06) : 962 - 964
  • [3] Primary infection with a multidrug-resistant HIV-1 strain
    Morelon, S
    Harzic, M
    Chadenat, ML
    Dupont, C
    Rouveix, E
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (18) : 2259 - 2260
  • [4] Ibalizumab for the treatment of multidrug-resistant HIV-1 infection
    Rizza, S. A.
    Bhatia, R.
    Zeuli, J.
    Temesgen, Z.
    DRUGS OF TODAY, 2019, 55 (01) : 25 - 34
  • [5] Ibalizumab: A Review in Multidrug-Resistant HIV-1 Infection
    Blair, Hannah A.
    DRUGS, 2020, 80 (02) : 189 - 196
  • [6] Ibalizumab: A Review in Multidrug-Resistant HIV-1 Infection
    Hannah A. Blair
    Drugs, 2020, 80 : 189 - 196
  • [7] Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection
    Kozal, Michael
    Aberg, Judith
    Pialoux, Gilles
    Cahn, Pedro
    Thompson, Melanie
    Molina, Jean-Michel
    Grinsztejn, Beatriz
    Diaz, Ricardo
    Castagna, Antonella
    Kumar, Princy
    Latiff, Gulam
    DeJesus, Edwin
    Gummel, Mark
    Gartland, Margaret
    Pierce, Amy
    Ackerman, Peter
    Llamoso, Cyril
    Lataillade, Max
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (13): : 1232 - 1243
  • [8] Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection
    Segal-Maurer, Sorana
    DeJesus, Edwin
    Stellbrink, Hans-Jurgen
    Castagna, Antonella
    Richmond, Gary J.
    Sinclair, Gary I.
    Siripassorn, Krittaecho
    Ruane, Peter J.
    Berhe, Mezgebe
    Wang, Hui
    Margot, Nicolas A.
    Dvory-Sobol, Hadas
    Hyland, Robert H.
    Brainard, Diana M.
    Rhee, Martin S.
    Baeten, Jared M.
    Molina, Jean-Michel
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (19): : 1793 - 1803
  • [9] Inflammation burden score in multidrug-resistant HIV-1 infection
    Clemente, Tommaso
    Caccia, Roberta
    Galli, Laura
    Galli, Andrea
    Poli, Andrea
    Marchetti, Giulia Carla
    Bandera, Alessandra
    Zazzi, Maurizio
    Santoro, Maria Mercedes
    Cinque, Paola
    Castagna, Antonella
    Spagnuolo, Vincenzo
    JOURNAL OF INFECTION, 2023, 86 (05) : 453 - 461
  • [10] Multidrug-resistant HIV-1 - Reply
    Gandhi, RT
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (10) : 1512 - 1512
12345